Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Roche

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|April 14, 2026
HIV Promoters Isolated from Brain and Peripheral Tissue of Virally Suppressed PWH Are Phylogenetically and Functionally SimilarJanna Jamal Eddine, Emily K Chalmers, Jingling Zhou, et al.
Journal of Medicinal Chemistry|September 29, 2006
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interactionDow Hurst, Uju Umejiego, Diane Lynch, et al.
Technical Innovations & Patient Support in Radiation Oncology|April 24, 2026
Implementation of surface-guided radiotherapy for motion management in liver SBRT: A scoping review and clinical workflow developmentOrla McKivitt, Michael Roche, Kate Lawless, et al.
Journal of Virology|February 25, 2011
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismMichael Roche, Martin R Jakobsen, Jasminka Sterjovski, et al.
Viruses|July 2, 2021
Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune CellsChristina Fichter, Anupriya Aggarwal, Andrew Kam Ho Wong, et al.
ACS Chemical Biology|June 26, 2014
Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entryXuyu Liu, Lara R Malins, Michael Roche, et al.
Journal of Leukocyte Biology|October 19, 2012
Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5Hamid Salimi, Michael Roche, Nicholas Webb, et al.
Journal of Virology|February 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferationJared Stern, Rory A Shepherd, Youry Kim, et al.
The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|April 14, 2026
HIV Promoters Isolated from Brain and Peripheral Tissue of Virally Suppressed PWH Are Phylogenetically and Functionally SimilarJanna Jamal Eddine, Emily K Chalmers, Jingling Zhou, et al.
Journal of Medicinal Chemistry|September 29, 2006
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interactionDow Hurst, Uju Umejiego, Diane Lynch, et al.
Technical Innovations & Patient Support in Radiation Oncology|April 24, 2026
Implementation of surface-guided radiotherapy for motion management in liver SBRT: A scoping review and clinical workflow developmentOrla McKivitt, Michael Roche, Kate Lawless, et al.
Journal of Virology|February 25, 2011
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismMichael Roche, Martin R Jakobsen, Jasminka Sterjovski, et al.
Viruses|July 2, 2021
Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune CellsChristina Fichter, Anupriya Aggarwal, Andrew Kam Ho Wong, et al.
ACS Chemical Biology|June 26, 2014
Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entryXuyu Liu, Lara R Malins, Michael Roche, et al.
Journal of Leukocyte Biology|October 19, 2012
Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5Hamid Salimi, Michael Roche, Nicholas Webb, et al.
Journal of Virology|February 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferationJared Stern, Rory A Shepherd, Youry Kim, et al.
The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Pageof 15